Pillar of Genomics | GenomeWeb

Pillar of Genomics

Premium

Tim Hunkapiller’s a kid off the farm whose sequencing and computational biology brainstorms shaped the genomics industry

 

By Meredith W. Salisbury

 

At first, Caltech rejected Tim Hunkapiller’s application for graduate studies. He doesn’t mind admitting that, but Caltech probably would, given how much the school makes in royalties off the patented four-color sequencer he helped develop in one of its labs.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.